Sage Therapeutics CEO Jeffrey Jonas' 2020 pay falls 53% to $4.7M
Sage Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
Sage Therapeutics reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, six executives at Sage Therapeutics received on average a compensation package of $2.7M, a 47% decrease compared to previous year.
Average pay of disclosed executives at Sage Therapeutics
Jeffrey M. Jonas, Chief Executive Officer, received $4.7M in total, which decreased by 53% compared to 2019. 58% of Jonas' compensation, or $2.7M, was in option awards. Jonas also received $484K in non-equity incentive plan, $698K in salary, $758K in stock awards, as well as $16K in other compensation.
Michael Cloonan, Chief Operating Officer, received a compensation package of $4.6M, which decreased by 7% compared to previous year. 55% of the compensation package, or $2.5M, was in option awards.
Anne Marie Cook, General Counsel, earned $2.1M in 2020, a 46% decrease compared to previous year.
Albert J. Robichaud, Chief Scientific Officer, received $2.1M in 2020, which decreases by 46% compared to 2019.
Kimi Iguchi, Chief Financial Officer, earned $2M in 2020, a 50% decrease compared to previous year.
Barry E. Greene, Chief Executive Officer, received $826K in 2020.
Related executives
Barry Greene
Sage Therapeutics
Chief Executive Officer
Jeffrey Jonas
Sage Therapeutics
Chief Innovation Officer
Kimi Iguchi
Sage Therapeutics
Chief Financial Officer
Michael Cloonan
Sage Therapeutics
Chief Operating Officer
Anne Cook
Sage Therapeutics
General Counsel
Albert Robichaud
Sage Therapeutics
Chief Scientific Officer
You may also like
Source: SEC filing on April 29, 2021.